<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02635581</url>
  </required_header>
  <id_info>
    <org_study_id>TT-01</org_study_id>
    <nct_id>NCT02635581</nct_id>
  </id_info>
  <brief_title>A DEXA Clinical Study to Evaluate the Osteointegrative Potential of Trabecular Titanium™</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Limacorporate S.p.a</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Limacorporate S.p.a</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this clinical trial is to evaluate the osteointegrative potential of the
      Trabecular TitaniumTM and to measure the pattern of changing in bone mineral density (BMD)
      around an uncemented acetabular cup, manufactured in Trabecular Titanium™ , during 60 months
      after surgery.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The percentage change of the bone mineral density (BMD) around the acetabular cups with DEXA scan</measure>
    <time_frame>From baseline to 5 year Follow-up</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Harris Hip Score (HHS)</measure>
    <time_frame>From baseline to 5 year Follow-up</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36 score</measure>
    <time_frame>From baseline to 5 year Follow-up</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">84</enrollment>
  <condition>Primary Total Hip Replacement</condition>
  <arm_group>
    <arm_group_label>DELTA TT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Delta TT acetabular cup</intervention_name>
    <arm_group_label>DELTA TT</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI&lt; 40 kg/m2

          -  Indication suitable to the implantation of Delta TT acetabular cup (First implant)

          -  Idiopathic osteoarthritis

          -  Avascular necrosis

          -  Post-traumatic arthritis

          -  Presence of sufficient periacetabular bone stock

          -  Ability to understand the investigation, cooperate with the investigational procedure
             and willing to return to the hospital for the required post-operative follow-ups

          -  Written informed consent

        Exclusion Criteria:

          -  Patients found unsuitable for an implantation of Delta TT acetabular cup (Revision)

          -  Patients aged 76 or older

          -  Haemophilic disease

          -  Femur neck fracture

          -  Insulin Dependent Diabetes Mellitus (IDDM)

          -  Severe kidney failure (grade 4)

          -  Not responder Hypo- or Hyperthyroidism

          -  Paget's disease

          -  Tumours

          -  Active or suspicious infections

          -  Neurosensory deficits or neuromuscular diseases

          -  Severe and impairing vascular diseases

          -  Known incompatibility or allergy to products materials

          -  Woman with pregnancy or childbearing capacity or breast-feeding

          -  Subjects already enrolled in other clinical trials
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Leo Massari</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedaliero-Universitaria di Ferrara, Arcispedale S. Anna</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Azienda Ospedaliero-Universitaria di Ferrara, Arcispedale S. Anna</name>
      <address>
        <city>Cona</city>
        <state>Ferrara</state>
        <zip>44124</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Dipartimento di Ortopedia, Traumatologia e Riabilitazione, Ospedale CTO, Clinica II</name>
      <address>
        <city>Torino</city>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Dipartimento di Ortopedia, Traumatologia e Riabilitazione, Ospedale CTO, Clinica I</name>
      <address>
        <city>Torino</city>
        <zip>10126</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliero-Universitaria di Udine, Santa Maria della Misericordia</name>
      <address>
        <city>Udine</city>
        <zip>33100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>March 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 15, 2015</study_first_submitted>
  <study_first_submitted_qc>December 16, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 21, 2015</study_first_posted>
  <last_update_submitted>March 1, 2016</last_update_submitted>
  <last_update_submitted_qc>March 1, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 2, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

